- Alcon: Developing Innovative Eye Care Treatments
Our mission is to provide innovative vision products that enhance quality of life by helping people see better From vision research to eye health, learn more at Alcon com
- Alcon Eye Care Products and Vision Correction | MyAlcon
At Alcon, your vision is at the heart of the moments that matter We aspire to lead the world in innovating, life-changing vision and eye care products
- Alcon - Wikipedia
Alcon Inc (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products It has a paper headquarters in Geneva , Switzerland but its operational headquarters are in Fort Worth, Texas , United States , where it employs about 4,500 people
- Alcon Agrees to Acquire STAAR Surgical
STAAR Surgical is a leader in refractive surgery using Implantable Collamer Lenses, offering solutions for moderate to high myopes Acquisition of STAAR is complementary to Alcon’s laser vision correction business and is expected to be accretive in year two Alcon to purchase all outstanding shares of STAAR for $28 per share in cash, valuing STAAR at approximately $1 5 billion in equity value
- Alcon to acquire STAAR Surgical for about $1. 5B | MedTech Dive
Alcon has agreed to buy implantable lens maker STAAR Surgical for about $1 5 billion in total equity value, the companies said Tuesday Alcon, which will purchase all outstanding shares of STAAR for $28 per share in cash, expects STAAR’s refractive surgery offerings to complement Alcon’s laser vision correction business
- About Us | Alcon
Alcon is the global leader in eye care, dedicated to helping people see brilliantly With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care
- Alcon agrees to acquire STAAR Surgical - ophthalmologytimes. com
Alcon has entered into a definitive merger agreement with STAAR Surgical Company, through which Alcon intends to acquire STAAR This is Alcon’s latest move in a string of acquisitions in 2025 1 Earlier this year, Alcon announced it acquired a majority interest in Aurion Biotech, 2 a clinical-stage company developing advanced cell therapies to treat eye diseases, and intends to acquire
- Eye Care, Relief, and Hygiene Products | Alcon
From dry eye relief to eye allergy drops with the #1 selling eye allergy itch relief brand, Alcon eye care products will keep your eyes feeling their best
|